Leukemia Clinical Trial Results

Browse clinical trials for Leukemia by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negati
  Phase 3 · National Cancer Institute (NCI) · Active, not recruiting · Sep 24, 2024
• Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patient
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Jan 25, 2023
• Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab
  Phase 3 · National Cancer Institute (NCI) · Active, not recruiting · Feb 2, 2026
• Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patie
  Phase 3 · National Cancer Institute (NCI) · Active, not recruiting · Aug 14, 2023
• BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Mye
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Mar 13, 2025
• Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  Phase 1 · Wake Forest University Health Sciences · Completed · Mar 23, 2026
• Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic S
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Mar 22, 2016
• Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia
  Phase 2 · M.D. Anderson Cancer Center · Terminated · Apr 13, 2021
• 05-001: Treatment of Acute Lymphoblastic Leukemia in Children
  Phase 3 · Dana-Farber Cancer Institute · Completed · Jun 14, 2017
• CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
  Phase 2 · M.D. Anderson Cancer Center · Completed · May 22, 2019
• Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenou
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Jul 10, 2012
• Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
  Phase 3 · National Cancer Institute (NCI) · Active, not recruiting · Dec 6, 2022
• Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblas
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Apr 26, 2017
• Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell A
  Phase 3 · National Cancer Institute (NCI) · Active, not recruiting · Feb 23, 2022
• BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
  Phase 2 · UNC Lineberger Comprehensive Cancer Center · Completed · Feb 10, 2025

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials